class name | count |
---|---|
Liliopsida | 55 |
class name | count |
---|---|
Amaryllidaceae | 55 |
br08003 Category | # of metabolite |
---|---|
Isoquinoline alkaloids | 3 |
br08003 Category | KEGG ID | KNApSAcK ID |
---|---|---|
Isoquinoline alkaloids | C08526 | C00001570 |
Isoquinoline alkaloids | C08534 | C00001578 |
Isoquinoline alkaloids | C12173 | C00024414 |
Isoquinoline alkaloids | C12173 | C00027607 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
---|---|---|---|---|---|---|
C00001570 |
Jilkon
/ Lycoremin / Lycoremine / Galanthamine / (-)-Galanthamine |
CHEMBL659
CHEMBL492193 CHEMBL1565544 CHEMBL1623394 CHEMBL1624158 |
D005702
|
104 / 57 / 53 | 3 / 25 | |
C00001578 |
Narwedine
|
CHEMBL2146604
|
C069154
|
|||
C00024389 |
Epigalanthamine
|
CHEMBL659
CHEMBL492193 CHEMBL1565544 CHEMBL1623394 CHEMBL1624158 |
104 / 57 / 53 | |||
C00024405 |
Lycoramine
/ Dihydrogalanthamine / 1,2-Dihydrogalanthamine |
CHEMBL2146605
|
||||
C00024411 |
N-Allylnorgalanthamine
|
CHEMBL399515
|
||||
C00024414 |
Norgalantamine
/ N-Norgalanthamine / N-Demethylgalanthamine |
CHEMBL1385
|
1 / 1 / 0 | |||
C00024417 |
O-Demethyllycoramine
|
|||||
C00024436 |
Sanguinine
|
CHEMBL1524
|
1 / 1 / 0 | |||
C00027607 |
Norgalantamine
/ N-Norgalanthamine / N-Demethylgalanthamine / (-)-N-Demethylgalanthamine |
CHEMBL1385
|
1 / 1 / 0 | |||
C00027608 |
(-)-N-Demethyllycoramine
|
|||||
C00027657 |
11alpha-Hydroxygalanthamine
|
|||||
C00028682 |
N-Formylgalanthamine
|
|||||
C00028725 |
Norlycoramine
|
|||||
C00028732 |
Norsanguinine
|
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P22303 | Acetylcholinesterase | Hydrolase | C00001570 C00024389 C00024414 C00024436 C00027607 | 1 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00001570 C00024389 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00001570 C00024389 | 0 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00001570 C00024389 | 2 / 2 |
P08246 | Neutrophil elastase | S1A | C00001570 C00024389 | 2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00001570 C00024389 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00001570 C00024389 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00001570 C00024389 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00001570 C00024389 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00001570 C00024389 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00001570 C00024389 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00001570 C00024389 | 2 / 2 |
P02545 | Prelamin-A/C | Unclassified protein | C00001570 C00024389 | 11 / 10 |
P00918 | Carbonic anhydrase 2 | Lyase | C00001570 C00024389 | 1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00001570 C00024389 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00001570 C00024389 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00001570 C00024389 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00001570 C00024389 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00001570 C00024389 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00001570 C00024389 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00001570 C00024389 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00001570 C00024389 | 0 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00001570 C00024389 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00001570 C00024389 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00001570 C00024389 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00001570 C00024389 | 0 / 1 |
Q13224 | Glutamate receptor ionotropic, NMDA 2B | NS | C00001570 C00024389 | 1 / 0 |
Q05586 | Glutamate receptor ionotropic, NMDA 1 | NS | C00001570 C00024389 | 1 / 0 |
Q12879 | Glutamate receptor ionotropic, NMDA 2A | NS | C00001570 C00024389 | 0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00001570 C00024389 | 1 / 8 |
P11473 | Vitamin D3 receptor | NR1I1 | C00001570 C00024389 | 2 / 3 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00001570 C00024389 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00001570 C00024389 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00001570 C00024389 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00001570 C00024389 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00001570 C00024389 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00001570 C00024389 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00001570 C00024389 | 0 / 0 |
P05067 | Amyloid beta A4 protein | Membrane receptor | C00001570 C00024389 | 2 / 2 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00001570 C00024389 | 1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00001570 C00024389 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00001570 C00024389 | 1 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00001570 C00024389 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00001570 C00024389 | 0 / 0 |
Q92630 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | CMGC dual-specificity kinase DYRK2 | C00001570 C00024389 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001570 C00024389 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00001570 C00024389 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00001570 C00024389 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00001570 C00024389 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00001570 C00024389 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00001570 C00024389 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00001570 C00024389 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00001570 C00024389 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00001570 C00024389 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00001570 C00024389 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00001570 C00024389 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00001570 C00024389 | 1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00001570 C00024389 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00001570 C00024389 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00001570 C00024389 | 1 / 0 |
P03956 | Interstitial collagenase | M10A | C00001570 C00024389 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00001570 C00024389 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00001570 C00024389 | 0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00001570 C00024389 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00001570 C00024389 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00001570 C00024389 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00001570 C00024389 | 2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00001570 C00024389 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00001570 C00024389 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00001570 C00024389 | 0 / 0 |
P06276 | Cholinesterase | Hydrolase | C00001570 C00024389 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00001570 C00024389 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00001570 C00024389 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00001570 C00024389 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00001570 C00024389 | 1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00001570 C00024389 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00001570 C00024389 | 2 / 1 |
P56817 | Beta-secretase 1 | A1A | C00001570 C00024389 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001570 C00024389 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00001570 C00024389 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00001570 C00024389 | 1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00001570 C00024389 | 1 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00001570 C00024389 | 1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00001570 C00024389 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001570 C00024389 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00001570 C00024389 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00001570 C00024389 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00001570 C00024389 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00001570 C00024389 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00001570 C00024389 | 0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00001570 C00024389 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00001570 C00024389 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001570 C00024389 | 0 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00001570 C00024389 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00001570 C00024389 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00001570 C00024389 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00001570 C00024389 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00001570 C00024389 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00001570 C00024389 | 1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | C00001570 C00024389 | 0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00001570 C00024389 | 0 / 0 |
Q13627 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | CMGC dual-specificity kinase DYRK1 | C00001570 C00024389 | 1 / 0 |
O00255 | Menin | Unclassified protein | C00001570 C00024389 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001570 C00024389 | 1 / 2 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
43 | ACHE, ACEE, ARACHE, N-ACHE, YT | acetylcholinesterase (EC:3.1.1.7) |
C00001570
|
1137 | CHRNA4, BFNC, EBN, EBN1, NACHR, NACHRA4, NACRA4 | cholinergic receptor, nicotinic, alpha 4 (neuronal) |
C00001570
|
1141 | CHRNB2, EFNL3, nAChRB2 | cholinergic receptor, nicotinic, beta 2 (neuronal) |
C00001570
|
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#104300 | Alzheimer disease; ad |
P05067
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605714 | Cerebral amyloid angiopathy, app-related |
P05067
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#615363 | Estrogen resistance; estrr |
P03372
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#613970 | Mental retardation, autosomal dominant 6; mrd6 |
Q13224
|
#614104 | Mental retardation, autosomal dominant 7; mrd7 |
Q13627
|
#614254 | Mental retardation, autosomal dominant 8; mrd8 |
Q05586
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
|
H00027 | Ovarian cancer |
P04626
(related)
|
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
H00056 | Alzheimer's disease (AD) |
P05067
(related)
|
H01185 | Cerebral amyloid angiopathy (CAA) |
P05067
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D000544 | Alzheimer Disease |
C00001570
|
D000647 | Amnesia |
C00001570
|
D054537 | Atrioventricular Block |
C00001570
|
D001321 | Autistic Disorder |
C00001570
|
D001919 | Bradycardia |
C00001570
|
D003072 | Cognition Disorders |
C00001570
|
D003693 | Delirium |
C00001570
|
D015140 | Dementia, Vascular |
C00001570
|
D003967 | Diarrhea |
C00001570
|
D062787 | Drug Overdose |
C00001570
|
D004421 | Dystonia |
C00001570
|
D006261 | Headache |
C00001570
|
D006948 | Hyperkinesis |
C00001570
|
D007022 | Hypotension |
C00001570
|
D007859 | Learning Disorders |
C00001570
|
D008133 | Long QT Syndrome |
C00001570
|
D020258 | Neurotoxicity Syndromes |
C00001570
|
D010243 | Paralysis |
C00001570
|
D010259 | Paranoid Disorders |
C00001570
|
D011041 | Poisoning |
C00001570
|
D049188 | Prenatal Injuries |
C00001570
|
D012640 | Seizures |
C00001570
|
D013575 | Syncope |
C00001570
|
D014202 | Tremor |
C00001570
|
D014839 | Vomiting |
C00001570
|